8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2016 / Meta-analysis with trial sequential analysis of RCTs
A meta-analysis with trial sequential analysis of 22 RCTs (1,251 subjects) evaluated the effects of berry consumption in healthy individuals and patients with CVD. Berry consumption significantly lowered LDL-cholesterol (WMD -0.21 mmol/L; 95% CI -0.34 to -0.07; P = 0.003), systolic blood pressure (WMD -2.72 mmHg; 95% CI -5.32 to -0.12; P = 0.04), fasting glucose (WMD -0.10 mmol/L; 95% CI -0.17 to -0.03; P = 0.004), and BMI (WMD -0.36 kg/m2; 95% CI -0.54 to -0.18; P < 0.00001). It also significantly reduced HbA1c (WMD -0.20%; P = 0.04) and TNF-α (WMD -0.99 pg/mL; P = 0.04), while other markers showed no significant changes.
Huang H, Chen G, Liao D, et al. Sci Rep, 2016. PMID 27006201
2016 / Meta-analysis of prospective clinical studies
A meta-analysis of 15 prospective clinical studies evaluated hemodynamic outcomes after acute energy drink intake. Systolic blood pressure increased significantly by 4.44 mm Hg (95% CI 2.71 to 6.17; n = 340) and diastolic pressure rose by 2.73 mm Hg (95% CI 1.52 to 3.95; n = 322). Heart rate changes were not statistically significant (0.80 beats per minute, 95% CI -1.26 to 2.87), while drinks delivering at least 200 mg caffeine raised systolic pressure by 6.44 mm Hg.
Shah SA, Chu BW, Lacey CS, et al. Ann Pharmacother, 2016. PMID 27340146
2016 / Systematic review and meta-analysis of randomized controlled trials
A meta-analysis evaluated 11 randomized controlled trials investigating Nigella sativa in 860 normotensive or hypertensive adults over an average of 8.3 weeks. Compared to control groups, Nigella sativa significantly reduced systolic blood pressure by 3.26 mmHg (95% CI: -5.10, -1.42) and diastolic blood pressure by 2.80 mmHg (95% CI: -4.28, -1.32). Powder formulations showed a greater blood-pressure-lowering effect than oil preparations.
Sahebkar A, Soranna D, Liu X, et al. J Hypertens, 2016. PMID 27512971
2015 / Systematic review and meta-analysis of randomized controlled trials
A meta-analysis analyzed 27 randomized controlled clinical trials involving 2,569 patients. For type 2 diabetes, berberine with lifestyle intervention or oral hypoglycemics tended to lower FPG, PPG, and HbA1c more than lifestyle intervention alone, placebo, or hypoglycemics alone, though berberine alone did not significantly differ from oral hypoglycemics. For hyperlipidemia, berberine combined with lifestyle intervention or lipid-lowering drugs was better at reducing TC and LDL-C and raising HDL-C. For hypertension, berberine with lifestyle intervention or hypotensors lowered blood pressure more than controls. No serious adverse reactions were reported, but the authors concluded that due to limited overall study quality, the therapeutic benefit could be substantiated to a limited degree.
Lan J, Zhao Y, Dong F, et al. J Ethnopharmacol, 2015. PMID 25498346
2015 / Systematic review and meta-analysis of randomized controlled trials
A meta-analysis of 46 randomized placebo-controlled trials with 4,541 participants found no effect of vitamin D supplementation on systolic blood pressure (effect size 0.0 mm Hg; 95% CI, -0.8 to 0.8) or diastolic blood pressure (effect size -0.1 mm Hg; 95% CI, -0.6 to 0.5). Individual patient data from 27 trials (3,092 participants) showed similar null effects. Subgroup analyses found no baseline factors predictive of response.
Beveridge LA, Struthers AD, Khan F, et al. JAMA Intern Med, 2015. PMID 25775274
2015 / Meta-analysis of randomized controlled trials
A meta-analysis evaluated 7 randomized placebo-controlled trials investigating garlic for blood pressure management in hypertensive patients. Compared to placebo, garlic significantly decreased systolic blood pressure (WMD: -6.71 mmHg; 95% CI: -12.44 to -0.99; P = 0.02) and diastolic blood pressure (WMD: -4.79 mmHg; 95% CI: -6.60 to -2.99; P < 0.00001). No serious adverse events were documented across the trials.
Xiong XJ, Wang PQ, Li SJ, et al. Phytomedicine, 2015. PMID 25837272
2015 / Prospective cohort studies and fixed-effects meta-analysis
Researchers analyzed the association between long-term intake of animal flesh and incident hypertension across three prospective cohorts: NHS, NHS II, and HPFS, followed by a fixed-effects meta-analysis. Compared with intake of less than 1 serving/month, consumption of at least 1 serving/day was associated with pooled hazard ratios of 1.30 (95% CI 1.23-1.39) for total meat, 1.22 (95% CI 1.12-1.34) for poultry, and 1.05 (95% CI 0.98-1.13) for seafood. Consuming any animal flesh at least 1 serving/day was linked to higher risk [pooled HR = 1.30 (95% CI 1.16-1.47)]. Seafood consumption showed a weak but significant trend toward increased hypertension risk, being associated with risk in HPFS and NHS II, but not NHS.
Shows an association, not proof of cause and effect.
Borgi L, Curhan GC, Willett WC, et al. J Hypertens, 2015. PMID 26237562
2014 / Systematic review and meta-analysis of controlled feeding trials
A systematic review and meta-analysis evaluated 8 isocaloric controlled feeding trials (n = 554 participants with and without hypertension) of at least 3 weeks duration to assess the effect of dietary pulses on blood pressure. When exchanged isocalorically for other foods, dietary pulses significantly lowered systolic blood pressure (MD = -2.25 mm Hg, 95% CI: -4.22 to -0.28, P = 0.03) and mean arterial blood pressure (MD = -0.75 mm Hg, 95% CI: -1.44 to -0.06, P = 0.03). Diastolic blood pressure was non-significantly lowered (MD = -0.71 mm Hg, 95% CI: -1.74 to 0.31, P = 0.17). Significant heterogeneity was observed for all outcomes.
Jayalath VH, de Souza RJ, Sievenpiper JL, et al. Am J Hypertens, 2014. PMID 24014659
2014 / Systematic review and meta-analysis
A systematic review and meta-analysis of 7 controlled clinical trials (311 participants) and 32 observational studies (21,604 participants) evaluated the relationship between vegetarian diets and blood pressure. In controlled trials, vegetarian diets were associated with reductions in mean systolic BP (-4.8 mm Hg; 95% CI, -6.6 to -3.1) and diastolic BP (-2.2 mm Hg; 95% CI, -3.5 to -1.0) compared with omnivorous diets. In observational studies, vegetarian diets were associated with lower mean systolic BP (-6.9 mm Hg; 95% CI, -9.1 to -4.7) and diastolic BP (-4.7 mm Hg; 95% CI, -6.3 to -3.1).
Yokoyama Y, Nishimura K, Barnard ND, et al. JAMA Intern Med, 2014. PMID 24566947
2014 / Mendelian randomisation meta-analysis
A Mendelian randomisation meta-analysis evaluated 261,991 individuals of European descent across 56 epidemiological studies. Carriers of the ADH1B rs1229984 A-allele consumed 17.2% fewer units of alcohol weekly (95% CI 15.6% to 18.9%) and had lower odds of coronary heart disease (OR 0.90, 95% CI 0.84 to 0.96) and ischaemic stroke (OR 0.83, 95% CI 0.72 to 0.95), with no association identified with combined stroke subtypes. Carriers also had lower systolic blood pressure (-0.88 mm Hg), interleukin-6 levels (-5.2%), waist circumference (-0.3 cm), and body mass index (-0.17 kg/m²).
Shows an association, not proof of cause and effect.
Holmes MV, Dale CE, Zuccolo L, et al. BMJ, 2014. PMID 25011450
2014 / Meta-analysis of randomized controlled trials
A meta-analysis of five articles examining six cohorts with 1,974 participants evaluated the effects of salt substitutes on blood pressure. Salt substitutes significantly lowered systolic blood pressure by 4.9 mm Hg (95% CI: -7.3 to -2.5 mm Hg; P < 0.001) and diastolic blood pressure by 1.5 mm Hg (95% CI: -2.7 to -0.3 mm Hg; P = 0.013). Substantial heterogeneity was observed for both systolic and diastolic outcomes.
Peng YG, Li W, Wen XX, et al. Am J Clin Nutr, 2014. PMID 25411279
2014 / Meta-analysis of randomized controlled clinical trials
A meta-analysis evaluated randomized controlled trials investigating the effects of garlic powder intake on cardiovascular disease risk factors. Garlic powder intake significantly reduced total cholesterol by -0.41 mmol/L (-15.83 mg/dL) and LDL-C by -0.21 mmol/L (-8.11 mg/dL). It also lowered fasting blood glucose by -0.96 mmol/L (-17.30 mg/dL), systolic blood pressure by -4.34 mmHg, and diastolic blood pressure by -2.36 mmHg.
Kwak JS, Kim JY, Paek JE, et al. Nutr Res Pract, 2014. PMID 25489404
2013 / Systematic review
A systematic review evaluated 16 randomized controlled trials (1,062 patients) and 11 observational studies (831 patients) on Nordic walking. Nordic walking demonstrated benefits for resting heart rate, blood pressure, aerobic capacity, peak oxygen consumption, and overall quality of life compared to brisk walking, and surpassed jogging on select endpoints.
Tschentscher M, Niederseer D, Niebauer J Am J Prev Med, 2013. PMID 23253654
2013 / Systematic review and meta-analysis of RCTs
A systematic review and meta-analysis of 15 randomized controlled trials examined the effects of aerobic endurance training lasting at least 4 weeks on ambulatory blood pressure in 633 healthy adults. Overall, endurance training significantly reduced daytime systolic blood pressure by -3.2 mmHg (95% CI, -5.0 to -1.3) and daytime diastolic blood pressure by -2.7 mmHg (95% CI, -3.9 to -1.5). No effect was observed on night-time blood pressure.
Cornelissen VA, Buys R, Smart NA J Hypertens, 2013. PMID 23325392
2013 / Systematic review and meta-analysis of randomized trials
In a meta-analysis of 34 trials with 3,230 participants lasting at least four weeks, modest salt reduction (mean urinary sodium change -75 mmol/24 h) reduced systolic blood pressure by 4.18 mm Hg (95% CI -5.18 to -3.18) and diastolic blood pressure by 2.06 mm Hg (-2.67 to -1.45). Significant falls occurred in hypertensive individuals (-5.39/-2.82 mm Hg) and normotensive individuals (-2.42/-1.00 mm Hg). Salt reduction caused small increases in plasma renin activity, aldosterone, and noradrenaline, but no significant changes in lipid concentrations.
He FJ, Li J, Macgregor GA BMJ, 2013. PMID 23558162
2013 / Systematic review and meta-analysis of randomized controlled trials
A meta-analysis of 34 randomized trials with 3,230 participants evaluated modest salt reduction lasting at least four weeks. Reducing 24-hour urinary sodium by 75 mmol lowered systolic blood pressure by 4.18 mmHg (95% CI: -5.18 to -3.18) and diastolic blood pressure by 2.06 mmHg (95% CI: -2.67 to -1.45). Blood pressure reductions occurred in hypertensive and normotensive individuals, alongside small increases in renin, aldosterone, and noradrenaline, but no significant changes in lipid levels.
He FJ, Li J, Macgregor GA Cochrane Database Syst Rev, 2013. PMID 23633321
2012 / Meta-analysis of randomized controlled trials
A meta-analysis of 11 randomized controlled trials evaluated the effect of dietary soy isoflavones on blood pressure. Overall, soy isoflavones resulted in a mean decrease of 2.5 mm Hg (95% CI: -5.35 to 0.34, P = 0.08) for systolic blood pressure (SBP) and 1.5 mm Hg (95% CI: -3.09 to 0.17, P = 0.08) for diastolic blood pressure (DBP) compared to placebo. In subgroup analyses of hypertensive subjects (5 trials), soy isoflavones significantly reduced SBP by -5.94 mm Hg (95% CI: -10.55 to -1.34, P = 0.01) and DBP by -3.35 mm Hg (95% CI: -6.52 to -0.19, P = 0.04). No significant reduction was found in normotensive subjects (6 trials; SBP: 0.29 mm Hg, P = 0.83; DBP: -0.43 mm Hg, P = 0.50). Authors noted larger trials are needed to confirm the findings.
Liu XX, Li SH, Chen JZ, et al. Nutr Metab Cardiovasc Dis, 2012. PMID 21310599
2012 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis of 42 RCTs involving 1,297 participants assessed the cardiovascular effects of chocolate, cocoa, and flavan-3-ols. Intake improved HOMA-IR (-0.67; 95% CI: -0.98, -0.36) via reductions in serum insulin, and enhanced FMD after chronic (1.34%; 95% CI: 1.00%, 1.68%) and acute (3.19%; 95% CI: 2.04%, 4.33%) intake. Reductions were seen in diastolic blood pressure (-1.60 mm Hg; 95% CI: -2.77, -0.43 mm Hg) and mean arterial pressure (-1.64 mm Hg; 95% CI: -3.27, -0.01 mm Hg). Evidence quality was low to moderate according to GRADE due to unclear reporting of allocation concealment, dropouts, missing outcome data, and biomarker heterogeneity.
Hooper L, Kay C, Abdelhamid A, et al. Am J Clin Nutr, 2012. PMID 22301923
2012 / Meta-analysis of randomized controlled trials
A systematic review and meta-analysis of 29 randomized controlled trials evaluated the effects of oral vitamin C supplementation (median dose: 500 mg/d; median duration: 8 wk) on blood pressure. Vitamin C supplementation led to pooled reductions of -3.84 mm Hg (95% CI: -5.29, -2.38 mm Hg; P < 0.01) in SBP and -1.48 mm Hg (95% CI: -2.86, -0.10 mm Hg; P = 0.04) in DBP. In hypertensive participants, reductions in SBP and DBP were -4.85 mm Hg (P < 0.01) and -1.67 mm Hg (P = 0.17), respectively. Effects were attenuated but remained significant after including 9 trials with imputed BP effects.
Juraschek SP, Guallar E, Appel LJ, et al. Am J Clin Nutr, 2012. PMID 22492364
2012 / Systematic review
A systematic review of 22 studies evaluated adult diabetes trends in mainland China from 2000 to 2010. Diabetes prevalence increased nationally from 2.6% to 9.7% over the decade. The condition was strongly associated with older age and was more prevalent in urban than rural populations, with common reported links to obesity, family history, and hypertension.
Li H, Oldenburg B, Chamberlain C, et al. Diabetes Res Clin Pract, 2012. PMID 22658670
2012 / Comparative risk assessment / systematic analysis
Investigators estimated deaths and DALYs attributable to 67 risk factors across 21 regions in 1990 and 2010 as part of the Global Burden of Disease Study 2010. In 2010, the leading global risk factor was high blood pressure (7.0% of global DALYs [95% UI 6.2-7.7]), followed by tobacco smoking (6.3%) and alcohol use (5.5%). Dietary risk factors and physical inactivity collectively accounted for 10.0% (95% UI 9.2-10.8) of global DALYs in 2010, with the most prominent dietary risks being diets low in fruits and diets high in sodium. Global disease burden shifted away from childhood communicable disease risks toward adult non-communicable disease risks, including increases in burden attributable to high body-mass index.
Shows an association, not proof of cause and effect.
Lim SS, Vos T, Flaxman AD, et al. Lancet, 2012. PMID 23245609
2011 / Meta-analysis of randomized controlled trials
A meta-analysis evaluated six randomized trials with 144 participants to examine caffeine's effect on intraocular pressure. In 103 healthy individuals, caffeine intake did not alter intraocular pressure at 0.5, 1, or 1.5 hours. However, in 41 patients with glaucoma or ocular hypertension, caffeine increased intraocular pressure significantly at all intervals: 0.347 mm Hg (95% CI, 0.078 to 0.616) at 0.5 hours, 2.395 mm Hg (1.741 to 3.049) at 1 hour, and 1.998 mm Hg (1.522 to 2.474) at 1.5 hours.
Li M, Wang M, Guo W, et al. Graefes Arch Clin Exp Ophthalmol, 2011. PMID 20706731
2011 / Systematic review and meta-analysis of clinical trials and epidemiological studies
A meta-analysis of 50 studies with 534,906 participants examined Mediterranean diet adherence. Combined prospective studies and trials showed adherence was associated with reduced metabolic syndrome risk (log hazard ratio: -0.69, 95% CI: -1.24 to -1.16). Clinical trials showed favorable changes in waist circumference (-0.42 cm, 95% CI: -0.82 to -0.02), HDL cholesterol (1.17 mg/dl, 95% CI: 0.38 to 1.96), triglycerides (-6.14 mg/dl, 95% CI: -10.35 to -1.93), systolic blood pressure (-2.35 mm Hg, 95% CI: -3.51 to -1.18), diastolic readings (-1.58 mm Hg, 95% CI: -2.02 to -1.13), and blood sugar (-3.89 mg/dl, 95% CI: -5.84 to -1.95).
NANO counterpoint →
Kastorini CM, Milionis HJ, Esposito K, et al. J Am Coll Cardiol, 2011. PMID 21392646
2010 / Systematic review of randomized controlled trials
A systematic review identified four randomized controlled trials totaling 390 patients assessing Hibiscus sabdariffa for primary hypertension. Two trials compared hibiscus to black tea, one to captopril, and one to lisinopril. Hibiscus showed greater blood pressure reduction than black tea but less than ACE inhibitors. However, all studies except one were short term and of poor quality (Jadad score <3), leading authors to conclude that the trials do not provide reliable evidence to support recommending hibiscus for primary hypertension.
Wahabi HA, Alansary LA, Al-Sabban AH, et al. Phytomedicine, 2010. PMID 19801187